Categories
- 10th Circuit
- 11th Circuit
- 1st Circuit
- 2nd Circuit
- 3rd Circuit
- 4th Circuit
- 5th Circuit
- 6th Circuit
- 7th Circuit
- 8th Circuit
- 9th Circuit
- Ability To Pay
- Affirmative Defenses
- AK-ED
- AL-ND
- Ala Sup. Ct.
- Allina
- Alternate Remedy
- Anti-Kickback Statute
- Attorney’s Fees
- AZ-D
- Brand Memo
- CA-11
- CA-CD
- CA-ED
- CA-ND
- Cal. Ct. App.
- Causation
- Civil Investigative Demands
- Civil Monetary Penalties
- Clinical Laboratories
- COFC
- Common-law Claims
- Complaints
- Compliance
- Confidentiality Agreements
- Constitutionality
- Constructive Discharge
- Corporate Integrity Agreements
- Counterclaims
- COVID-19
- D. Mass.
- D.C. Circuit
- Damages
- DC-D
- Discovery
- Dismissal
- DME
- Dodd-Frank
- Education
- Enforcement
- Escobar
- Ethics
- Express/Implied Certification
- Fair Market Value
- False Certification
- False Statements
- Falsity
- FCA Liability
- FCPA
- FDA
- FDCA
- Financial Services
- First Amendment
- First-to-File
- FL-MD
- FL-ND
- FL-SD
- Fraud on the FDA
- Fraudulent Inducement
- GA-MD
- GA-ND
- GA-SD
- General
- GMP
- Government Action Bar
- Government Contracts
- Government Immunity
- Government Knowledge
- Granston Memo
- Health Care Providers
- HIPAA
- IA-ND
- ICFPA
- IL-CD
- IL-ND
- IL-SD
- Illinois Appellate Court
- Implied Certification
- IN-SD
- Individual Liability
- Insurance Coverage
- Interlocutory Appeal
- Intervention
- Iqbal/Twombley
- Knowledge/Scienter
- KY-ED
- KY-WD
- La Sup. Court
- LA-ED
- Laboratories
- Legislation
- Litigation Funding
- MA-D
- Materiality
- MD-D
- Medical Billing Fraud
- Medical Coding
- Medical Devices
- Medical Necessity
- Medicare Advantage
- Medicare/Medicaid
- MI-ED
- Minority Business Enterprise
- MN-D
- MO-ED
- MO-WD
- Motion to Dismiss
- MS-ND
- MS-SD
- N.J. Supreme Court
- N.Y. Supreme Court
- NC-ED
- NC-WD
- NJ-D
- NV-D
- NY-ED
- NY-SD
- NY-WD
- Off-Label
- OH-ND
- OH-SD
- OIG Exclusion Criteria
- Original Source
- Overpayments
- PA-ED
- PA-WD
- Part D
- Patient Assistance Programs
- Patient Protection and Affordable Care Act
- Penalties
- Pharmaceutical Manufacturers
- Pharmaceuticals
- Pharmacies
- Private Equity
- Privilege Issues
- Procedure
- Proposed NY Whistleblower Program
- Providers
- Public Disclosure
- Relators
- Release
- Reports
- Retaliation
- Reverse False Claims
- Rule 12(b)(6)
- Rule 9(b)
- Sampling
- SC-D
- SD-FL
- Seal
- SEC Whistleblower Program
- Securities Disclosures
- Self-Disclosure
- Settlement
- SNFs
- Standing
- Stark Law
- State Agencies
- State/Local FCA
- Statistical Sampling
- Statute of Limitations
- Successor Liability
- Summary Judgment
- Taxes
- Telehealth
- TN-ED
- TN-MD
- TX-ND
- TX-SD
- TX-WD
- U.S. Supreme Court
- U.S. Supreme Court
- Uncategorized
- Upcoding
- UT-D
- VA-ED
- VA-WD
- Voluntary Disclosure
- Voluntary Dismissals
- WI-ED
- Worthless Services
- WV-SD